McKesson, mscripts partner to boost adherence via mobile Rx coupons

SAN FRANCISCO — Mobile pharmacy platform mscripts announced Monday a partnership with McKesson Patient Relationship Solutions, the company’s provider of patient adherence programs through manufacturer sponsorships. The partnership will allow patients to receive coupons from manufacturers via text message or mobile app, connecting mscripts’ 6,000-pharmacy network with MPRS’s adherence programs and savings offerings that support more than 500 branded products. 

 

The aim of the partnership is to boost adherence among patients — something a recent study published in JAMA Internal Medicine has found can be improved by text message reminders.

 

“At MPRS, we’re focused on building integrated adherence solutions that address key touch points throughout the patient experience. Mobile and pharmacy are channels critical to advancing that strategy,” Derek Rago, MPRS VP and general manager, said. “Our partnership with mscripts is particularly exciting because it fully leverages the power of mobile while actively strengthening the pharmacist-patient relationship. The result is brand teams are now able to deliver cost savings for medications—directly to a preferred engagement medium, the patient’s mobile phone—securely and in real-time—from a key trusted healthcare provider, their pharmacist.”

 

According to mscripts, its targeted mobile outreach, which is sent on behalf of a patient’s pharmacy, can drive adherence gains of up to 2.9 times over patients who don’t reveive mobile outreach and their coupons can see click-through rates of up to 35%. 

 

“The partnership delivers valuable copay savings directly to a patient’s mobile phone exactly when they need them, whether it’s a prescription ready for refill or pick up. The coupons are easy to view and redeem, saving both the pharmacy and the patient time,” mscripts CEO Mark Cullen said. “We’re thrilled to partner with MPRS to help our pharmacies extend cost savings to their patients and enable more people to better afford their medication.”